CIK 0001553643 · Non-accelerated filer<br>Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 455401931
- Phone
- 646 876 3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- Open-market buys, last 90 days
- $1,671,990
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,671,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-25 | Ence Chuck CA and CO | Grant or award · Stock Option (right to buy) | +321,238 | 518,361 | ||
| 2023-05-25 | CASAMENTO CHARLES J Director | Grant or award · Stock Option (right to buy) | +92,958 | 150,000 | ||
| 2023-05-23 | O'Gorman Cedric Chief Medical Officer | Purchase | +10,000 | $3.18 | $32K | 10,121 |
| 2023-01-06 | O'Gorman Cedric Chief Medical Officer | Grant or award · Stock Option (right to buy) | −400,000 | 400,000 | ||
| 2022-12-16 | TRAVERSA SERGIO Chief Executive Officer | Other disposition · Stock Option (right to buy) | −300,000 | 0 | ||
| 2022-12-16 | Shenouda Maged CFO | Other disposition · Stock Option (right to buy) | −200,000 | 0 | ||
| 2022-12-16 | Ence Chuck CA and Compliance Officer | Other disposition · Stock Option (right to buy) | −200,000 | 0 | ||
| 2022-12-16 | TRAVERSA SERGIO Chief Executive Officer | Grant or award · Stock Option (right to buy) | +323,517 | 323,517 | ||
| 2022-12-16 | Shenouda Maged Chief Financial Officer | Grant or award · Stock Option (right to buy) | +194,917 | 194,917 | ||
| 2022-12-16 | SCHMIDT ERIC THOMAS Director | Grant or award · Stock Option (right to buy) | +57,042 | 57,042 | ||
| 2022-12-16 | Kelly Paul Edward Director | Grant or award · Stock Option (right to buy) | +57,042 | 57,042 | ||
| 2022-12-16 | GLASSPOOL JOHN Director | Grant or award · Stock Option (right to buy) | +57,042 | 57,042 | ||
| 2022-12-16 | Ence Chuck CA and CO | Grant or award · Stock Option (right to buy) | +197,123 | 197,123 | ||
| 2022-12-16 | CASAMENTO CHARLES J Director | Grant or award · Stock Option (right to buy) | +57,042 | 57,042 | ||
| 2022-12-08 | TRAVERSA SERGIO Chief Executive Officer | Purchase | +55,250 | $2.10 | $116K | 144,024 |
| 2022-07-01 | TRAVERSA SERGIO Chief Executive Officer | Option exercise | +13,755 | $16.00 | $220K | 102,529 |
| 2022-07-01 | TRAVERSA SERGIO Chief Executive Officer | Sale | −839 | $18.48 | $16K | 101,690 |
| 2022-07-01 | TRAVERSA SERGIO Chief Executive Officer | Sale | −8,848 | $18.45 | $163K | 92,842 |
| 2022-07-01 | TRAVERSA SERGIO Chief Executive Officer | Sale | −4,068 | $18.32 | $75K | 88,774 |
| 2022-07-01 | TRAVERSA SERGIO Chief Executive Officer | Option exercise · Stock Option (right to buy) | −13,755 | 0 |
Page 5 of 9 · 178 trades